*Correspondence: Pengyun Qiao, [email protected]
As a GLP-1 receptor agonist licensed in the UK for type 2 diabetes, Ozempic slows gastric emptying and alters gut motility throughout the digestive tract
MAT is evidence-based and effective, but it remains underused
Many users report nothing noticeable during this window, and that doesn't necessarily mean the compound isn't working senescent cell clearance is a biological process, not a feeling
Ozempics more rapid uptitration may achieve results sooner but can be more stomach upsetting for certain individuals
Jafarzadeh, S., Abdolmaleki, K., Javanmardi, F., Hadidi, M., and Mousavi Khaneghah, A., Int